Studies of antibiotic persistence in the therapy of experimental pyelonephritis: insoluble tetracyclines in normal and pyelonephritic rats.
D000273:Adipose Tissue / Q000032:analysis; D000818:Animals; D004927:Escherichia coli Infections; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D008297:Male; D009132:Muscles / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D010118:Oxytetracycline / Q000627:therapeutic use; D011704:Pyelonephritis / Q000188:drug therapy* / Q000209:etiology; D051381:Rats; D011919:Rats, Inbred Strains; D012995:Solubility; D013154:Spleen / Q000032:analysis; D013752:Tetracycline / Q000008:administration & dosage / Q000032:analysis / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors; D014316:Tritium
D014316:Tritium; D013752:Tetracycline; D010118:Oxytetracycline